Clinical and molecular classification of cardiomyopathies

Clinical and molecular classification of cardiomyopathies

The term "cardiomyopathies" was used for the first time 55 years ago, in 1957. Since then awareness and knowledge of this important and complex group of heart muscle diseases have improved substantially. Over these past five decades a large number of definitions, nomenclature and schemes, have been advanced by experts and consensus panel, which reflect the fast and continued advance of the scie...

Cardiomyopathies: Classification, Clinical Characterization, and Functional Phenotypes

1 Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA 2 Department of Clinical Pharmacology, Kyushu University Graduate School of Medicine, Fukuoka 8128582, Japan 3 Department of Neurobiology, Physiology and Behavior, University of California, Davis, CA 95616, USA 4 Department of Physiology and Biophysics, Boston University Scho...

Classification and Definitions of Cardiomyopathies

Cardiomyopathies are an important and heterogeneous group of diseases. The awareness and knowledge of these diseases in both the public and medical communities historically has been impaired by persistent confusion surrounding definitions and nomenclature. Classification schemes, of which there have been many, (Thiene et al., 2000, 2004; Richardson et al., 1996) are potentially useful in drawin...

Classification of the secondary cardiomyopathies

SECONDARY cardiomyopathy is defined as heart muscle disease of known cause or association. Naming particular diseases is preferable where individual conditions are being referred to e.g. myocardial sarcoid, cardiac amyloidosis, scleroderma heart disease, since the term cardiomyopathy without qualification is generally accepted as referring to the primary forms. Nevertheless, a convenient collec...

Definition and classification of the cardiomyopathies.